Potent anti-inflammatory activity of novel microtubule-modulating brominated noscapine analogs.

• Main Authors: Susu Zughaier, Prasanthi Karna, David Stephens, Ritu Aneja
• Format: Article
• Language: English
• Published: Public Library of Science (PLoS) 2010-02-01
• Series: PLoS ONE
• Online Access: http://europepmc.org/articles/PMC2820095?pdf=render

Noscapine, a plant-derived, non-toxic, over-the-counter antitussive alkaloid has tubulin-binding properties. Based upon the structural resemblance of noscapine to colchicine, a tubulin-binding anti-inflammatory drug, noscapine and its semi-synthetic brominated analogs were examined for in vitro anti-inflammatory activity. Brominated noscapine analogs were found to inhibit cytokine and chemokine release from macrophage cell lines but did not affect cell viability. Brominated noscapine analogs demonstrated anti-inflammatory properties in both TLR- and non-TLR induced in vitro innate immune pathway inflammation models, mimicking septic and sterile infection respectively. In addition, electron microscopy and immunoblotting data indicated that these analogs induced robust autophagy in human macrophages. This study is the first report to identify brominated noscapines as innate immune pathway anti-inflammatory molecules.